Trimekor MR coated tablets 35mg №60

Use: - Long-term therapy for ischemic heart disease (IHD), prevention of angina attacks (monotherapy or as part of combination therapy). - Treatment of cochleo-vestibular disorders of ischemic origin, such as dizziness, tinnitus, hearing impairment. - Chorioretinal vascular disorders with an ischemic component. How to take: - Trimecor MR is prescribed 1 tablet 2 times a day during meals (morning and evening). - The duration of therapy is determined individually by the doctor. Contraindications: - Hypersensitivity to trimetazidine or any of the excipients of the drug. - Severe renal impairment (creatinine clearance less than 30 ml/min). - Parkinson's disease, symptoms of parkinsonism, tremor, restless legs syndrome and other related movement disorders. - Trimetazidine is not recommended for patients under 18 years of age due to insufficient clinical data. Storage: - Store at a temperature from 10degreeC to 25degreeC in a place inaccessible to children. - The shelf life of the drug is 3 years. - The drug should not be used after the expiration date.